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RNA-binding proteins are at the heart of posttran-
scriptional gene regulation, coordinating the pro-
cessing, storage, and handling of cellular RNAs.
We show here that GRSF1, previously implicated in
the binding and selective translation of influenza
mRNAs, is targeted to mitochondria where it forms
granules that colocalize with foci of newly synthe-
sized mtRNA next to mitochondrial nucleoids.
GRSF1 preferentially binds RNAs transcribed from
three contiguous genes on the light strand of mtDNA,
the ND6 mRNA, and the long noncoding RNAs for
cytb and ND5, each of which contains multiple con-
sensus binding sequences. RNAi-mediated knock-
down of GRSF1 leads to alterations in mitochondrial
RNA stability, abnormal loading of mRNAs and
lncRNAs on the mitochondrial ribosome, and im-
paired ribosome assembly. This results in a specific
protein synthesis defect and a failure to assemble
normal amounts of the oxidative phosphorylation
complexes. These data implicate GRSF1 as a key
regulator of posttranscriptional mitochondrial gene
expression.
INTRODUCTION
RNA-binding proteins (RBPs) play key roles in all steps of post-
transcriptional regulation of RNAs, including splicing, polyade-
nylation, RNA transport and localization, RNA stability, and
translation. Mammalian cells contain thousands of RBPs that
bind unique mRNAs via RNA-binding domains in a sequence-
and structure-specific manner (Glisovic et al., 2008; Lunde
et al., 2007). The posttranscriptional regulation of mRNAs is
thus an important element in protein expression in eukaryotes.
In many instances multiple functionally related mRNAs have
been shown to be coordinately regulated by RBPs in ribonu-
cleoprotein (RNP) complexes, and this has led to the concept
of an RNA regulon (Keene, 2007). RBPs can also consolidate
mRNAs into RNA granules that are translationally silent,
to coordinate early developmental programs (Anderson and
Kedersha, 2009), to respond to cellular stresses (Anderson
and Kedersha, 2009; Buchan and Parker, 2009), or as a way to386 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.regulate local translation at neuronal synapses (Liu-Yesucevitz
et al., 2011).
The mitochondrial genome (mtDNA) encodes 13 polypeptides
that are translated on dedicated mitochondrial ribosomes, but
little is known about the mechanisms of posttranscriptional
handling of mitochondrial mRNAs. To date, only two mitochon-
drial mRNA-binding proteins have been extensively character-
ized, LRPPRC (Mootha et al., 2003) and SLIRP (Baughman
et al., 2009). Mutations in LRPPRC cause the French-Canadian
form of Leigh syndrome, an early onset neurodegenerative dis-
ease that is associated with tissue-specific cytochrome c
oxidase (COX) deficiency (Mootha et al., 2003). LRPPRC and
SLIRP form a RNP complex (Sasarman et al., 2010) that binds
mostmitochondrialmRNAs and is important for themaintenance
of their poly(A) tails (Chujo et al., 2012; Ruzzenente et al., 2012).
LRPPRC belongs to the pentatricopeptide repeat (PPR) family
of RBPs, which has hundreds of members in vascular land
plants (Schmitz-Linneweber and Small, 2008). In mammalian
mitochondria, six additional PPR proteins have been described,
and all localize to mitochondria: POLRMT (the mitochondrial
RNA-polymerase), PTCD1, PTCD2, PTCD3, MRPS27, and mito-
chondrial RNase P protein 3 (MRPP3) (Rorbach and Minczuk,
2012). MRPP3 and PTCD1 play a role in mitochondrial tRNA pro-
cessing (Sanchez et al., 2011). PTCD3 binds mitochondrial 12S
rRNA and is tightly associated with the mitochondrial small ribo-
somal subunit (mt-SSU); however, its exact molecular function
remains unknown (Davies et al., 2009; Haque et al., 2011).
MRPS27 is a protein of the mt-SSU that associates with the
12S rRNA and tRNAGlu, and while it is essential for mitochondrial
translation, knockdown of the protein does not affect RNA pro-
cessing or stability (Davies et al., 2012). PTCD2 has been shown
to be important for the processing of the cytochrome b (cyt b)
primary transcript (Xu et al., 2008). These studies provide clear
evidence of the essential role of mitochondrial RBPs in mito-
chondrial RNA metabolism, and consequently in mitochondrial
protein synthesis.
In our investigations of the genetic causes of humanmitochon-
drial translation defects, we identified mutations in C12orf65,
a mitochondrial protein possessing a class I release factor motif
(GGQ) present in prokaryotic translation termination factors (An-
tonicka et al., 2010). C12orf65 belongs to a family of four such
factors in mammalian mitochondria, which includes mtRF1,
mtRF1L, and ICT1. Its role in mitochondrial translation termina-
tion is, however, unclear, as mtRF1L appears to be both neces-
sary and sufficient for terminating the synthesis of all mitochon-
drial polypeptides (Chrzanowska-Lightowlers et al., 2011). To
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epitope-tagged version of the protein to identify interacting pro-
tein partners. This analysis identified GRSF1 (G-rich sequence
binding factor 1), previously characterized as a cytoplasmic
poly(A)+ mRNA-binding protein (Kash et al., 2002; Qian and
Wilusz, 1994).
GRSF1 belongs to a family of ubiquitously expressed proteins
that have been implicated in splicing, polyadenylation, capping,
export, and translation of cellular and viral mRNAs (Jablonski
and Caputi, 2009; Kash et al., 2002; Schaub et al., 2007). It
contains three RRM (RNA-binding) domains, and was reported
to bind the 50UTR of influenza virus nucleocapsid protein via an
AGGGU motif, and recruit it to the polyribosome (Kash et al.,
2002; Park et al., 1999). GRSF1 has also been implicated in
murine embryogenesis as a target of theWnt/b-catenin signaling
pathway (Lickert et al., 2005), and as a translational regulator of
glutathione peroxidase 4 (Ufer et al., 2008).
Here we show that GRSF1 is predominantly a soluble mito-
chondrial protein that localizes to RNA granules and coordi-
nates posttranscriptional storage and handling of mitochondrial
mRNAs and long noncoding RNAs (lncRNAs).
RESULTS
GRSF1 Is a Soluble Mitochondrial Protein
GRSF1 is a 53 kDa protein (480 amino acids) that is predicted to
be localized to mitochondria by four mitochondrial targeting
prediction programs (Mitoprot, Mitopred, TargetP, Predator). It
is also present in the Mitocarta proteomic database (Pagliarini
et al., 2008). A shorter transcript (318 amino acids) using an alter-
native start site has been described (NCBI, Ensembl); however,
there is no experimental confirmation of this splice variant. We
confirmed the mitochondrial localization of GRSF1 by indirect
immunofluorescence in a human fibroblast cell line (Figure 1A),
and by subcellular fractionation of HEK293 cells (Figure 1B).
GRSF1 was found exclusively in mitochondria, and, unexpect-
edly, appeared, by immunofluorescence detection, to be con-
centrated in specific foci in themitochondrial network (Figure 1A).
GRSF1 is not predicted to contain any transmembrane domains,
and alkaline carbonate extraction of mitochondria confirmed
that it is a solublemitochondrial protein (Figure 1C). To determine
if GRSF1 exists in a stable complex with other proteins, two-
dimensional blue native gel electrophoresis (BN-PAGE) (Fig-
ure 1D) and size exclusion chromatography (Figure 1E) were
performed. Both experiments showed that GRSF1 exists pri-
marily as a monomer, although a small amount of GRSF1 was
observed in higher-molecular-weight fractions (Figure 1E).
GRSF1 Is Required for Mitochondrial Translation and
Assembly of the OXPHOS Complexes
To investigate the function of GRSF1 in mitochondria, we used
siRNA-mediated knockdown of GRSF1 in cultured human fibro-
blasts. Three different siRNA constructs produced a graded
decrease in the steady-state levels of GRSF1 from about 5%
of control levels with siRNA1 to 40% of control levels with
siRNA3 (Figure 2A). BN-PAGE analysis showed that the knock-
down of GRSF1 resulted in a combined OXPHOS assembly
defect, with the prominent loss of complexes I, III, IV, and V (Fig-
ure 2B), the extent of which depended on the residual level ofCeGRSF1. COX activity was 58%, 77%, and 98% of control for
siRNAs1-3 respectively, consistent with the severity of the defect
in COX assembly. To test whether the assembly defects resulted
from a defect in mitochondrial protein synthesis, we pulse
labeled the mitochondrial translation products with a mixture of
[35S]-methionine and [35S]-cysteine in the presence of emetine,
an inhibitor of cytosolic translation (Figure 2C). We observed
a global decrease in mitochondrial translation, consistent with
the magnitude of the corresponding OXPHOS assembly defect
(55%, 69%, and 86% of control for siRNAs1-3, respectively).
The defect was, however, not uniform. The synthesis of three
polypeptides in particular, the complex I subunits ND5 and
ND6, and the complex III subunit cyt b, was markedly reduced,
while the synthesis of ND3, ATP6, and ND4L/ATP8 was not
significantly different than control (Figures 2C and 2D). This
pattern has not been reported previously in the context of other
mitochondrial translation defects (Antonicka et al., 2006, 2010;
Smeitink et al., 2006).
GRSF1 was shown to bind G-rich elements in the 50UTRs
of several cytoplasmic and proviral RNAs, with the consensus
motif being AGGGD, where D is either A, U, or G (Park et al.,
1999; Schaub et al., 2007; Ufer et al., 2008). Analysis of the
coding sequence of all mitochondrial transcripts revealed that
the mRNA for ND6 is the most G-rich sequence (35%) and
contains four consensus motifs, while the COX I and COX III
mRNAs contain three, ND1 mRNA contains two, and cyt b
mRNA contains one. The mRNAs for COX II, ND2, ND3, ND4,
ND4L, ND5, ATP6, and ATP8 do not contain an AGGGD
consensus motif.
Lack of GRSF1 Leads to Altered Steady-State Levels of
Mitochondrial rRNAs and mRNAs
We next used northern blot (Figure 3A) and qRT-PCR analyses
(see Table S1 online) to investigate if low levels of GRSF1 had
an effect on the steady-state levels of mitochondrial transcripts.
Themajority of transcripts were reduced to about 60%of control
(ND5, COX I, ND4/ND4L, COX II, ATP6/8, cyt b, and 12S rRNA);
however, the transcripts for ND3 and COX III were not affected,
while the transcripts for ND1 and ND2 were increased (to 134%
and 174% of control, respectively), and the 16S rRNA transcript
was reduced to 26% of control (Figure 3A, Table S1). Detection
of the ND6 transcript was hindered by the fact that the 30UTR of
the ND5 transcript covers the entire sequence complimentary to
the ND6 gene (Temperley et al., 2010). Thus a double-stranded
DNA probe detected both ND5 and ND6 transcripts (Figure 3B).
Three long noncoding RNAs complimentary to the genes encod-
ingND5,ND6, and cyt b have been identified by RNAseq, further
complicating this analysis (Rackham et al., 2011). In order to
detect the ND6 transcript specifically, we used a ‘‘primer’’ probe
consisting of a mix of three primers complimentary to three
different regions of the coding sequence of the ND6 gene. This
probe detected prominent transcripts of 3,200 nt (polycistronic
transcript) and 1,600 nt (lncND5/ND6 transcript) similar to the
dsND6 probe, and, on longer exposure, an 1,100 nt transcript.
The 30 end of the ND6 transcript was recently reported to be
33/34 nt by 30RACE analysis (Mercer et al., 2011), which would
predict a mature transcript of about 560 nt, but such a species
has not been reported by northern blot analysis. The 1,100 nt
transcript, which has been reported previously (Guan et al.,ll Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc. 387
Figure 1. Mitochondrial Localization of GRSF1 Protein
(A) Immunofluorescence analysis of human fibroblasts with anti-GRSF1 and anti-SDHA (mitochondrial marker) antibodies.
(B) HEK293 cells were fractionated as described in the Experimental Procedures; total homogenate, cytoplasmic, and mitochondrial proteins were separated by
SDS-PAGE; and individual proteins were detected using specific antibodies.
(C) GRSF1 is a soluble protein, as shown by alkaline carbonate extraction of HEK293 mitochondria. The membrane-bound COX II and membrane-associated
SDHA were used as controls.
(D) Two-dimensional BN-PAGE/SDS-PAGE electrophoresis of control fibroblasts. The positions of the COX and prohibitin complexes are shown.
(E) Mitochondria from control fibroblasts were fractionated by FPLC, and collected fractions were separated by SDS-PAGE. The positions of LRPPRC/SLIRP
complex (250 kDa), EFTu (50 kDa), and EFTs (30 kDa) proteins were used for calibration.
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down cells treated with siRNA1 and siRNA2, indicating that
GRSF1 is necessary for the stability of this low-abundance tran-
script. Although there was a clear and variable effect of GRSF1
knockdown on the steady-state levels of rRNAs and mRNAs,
the change in the level of the mRNA was not generally a reliable
predictor of the rate of synthesis of the individual polypeptides.
The above analysis did not reveal any evidence for an increase
in unprocessed mitochondrial transcripts in GRSF1 knockdown
cells (even on overexposed northern blots, Figure 3B), suggest-
ing that GRSF1 is not essential for maturation of the primary388 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.polycistronic transcripts. To further test this, we interrogated
several gene junctions in precursor transcripts by qRT-PCR
looking for increases in unprocessed transcripts in GRSF1
knockdown cells (Figure S1). The polycistronic transcripts of
mtDNA are processed primarily by RNase P and RNase Z
(ELAC2) at the 50 and 30 ends of the tRNA genes that punctuate
the genome (Brzezniak et al., 2011; Sanchez et al., 2011). The
mitochondrial RNase P is composed of three protein subunits
(MRPP1–3) but lacks an RNA component (Holzmann et al.,
2008). Processing of these same junctions in precursor tran-
scripts had previously been investigated in cells in which
Figure 2. The Lack of GRSF1 Protein
Results in a Mitochondrial Translation
Defect
(A) siRNA-mediated knockdown of GRSF1. SDS-
PAGE analysis shows a graded decrease in
GRSF1 with the three different siRNAs. Anti-
bodies against individual subunits of complex V
(a-ATPase), complex III (Core 1), and complex IV
(COX I) indicate the decreased steady-state levels
of OXPHOS proteins. Porin and SDHA antibodies
were used as loading controls.
(B) BN-PAGE analysis of GRSF1 knockdown cells
shows decreased assembly of OXPHOS com-
plexes revealed by subunit-specific antibodies for
each of the five OXPHOS complexes (Co I–Co V).
(C) Pulse-labeling translation assay of the 13
mitochondrial polypeptides (seven subunits of
complex I [ND], three subunits of complex IV
[COX], two subunits of complex V [ATP], and one
subunit of complex III [cyt b]) shows a specific
translation defect in GRSF1 knockdown cells.
(D) Quantification of three independent mito-
chondrial translation assays (expressed as per-
centage of controls). The bars represent themean,
and error bars represent the standard error of
the mean.
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knockdown of MRPP1, MRPP3, or ELAC2 (Sanchez et al.,
2011), providing a positive control for mitochondrial RNA-pro-
cessing defects. Our analysis showed that the levels of most of
the unprocessed transcripts in GRSF1 knockdown cells were
near background as compared with those observed in cells
with decreased processing enzyme activity (Sanchez et al.,
2011). For instance, the COX I-COX II and COXII-ATP8 precur-
sors were increased more than 100-fold when MRPP1 was
knocked down (Sanchez et al., 2011), but there was no enrich-
ment for these unprocessed species in GRSF1 knockdown cells.
Therewere small increases in the levels of unprocessed 12S-16S
rRNA and ND6-cytb in GRSF1 knockdown cells, but these are
more than an order of magnitude less than seen with the
MRPP1 knockdown. Importantly, the levels of several different
mitochondrial tRNAs were unaffected by the knockdown of
GRSF1 (Figure 3C).
GRSF1 Preferentially Binds Light-Strand Transcripts
and Is Present in RNA-Rich Foci
In order to identify the RNA species bound by GRSF1, we immu-
noprecipitated GRSF1 from mitochondria of HEK293 cells and
isolated the coimmunoprecipitated RNA. Strand-specific qRT-
PCR analysis showed that three contiguous RNAs viz. ND6
mRNA and two lncRNAs (cytb and ND5) transcribed from the
light-strand promoter were selectively enriched by 25- to 40-
fold in the immunoprecipitate (Figure 4A). The distribution of
the reported GRSF1 consensus binding sites (AGGGD) in
mtDNA transcripts is shown in Figure 4B. As mentioned above,
the ND6 mRNA contains four such motifs, while the lnccyt bCell Metabolism 17, 386–3RNA contains ten and the lncND5 RNA
21, consistent with the large selective
enrichment of these RNA species in thisexperiment. The steady-state levels of the lncRNAs were
decreased by about half in GRSF1 knockdown cells (Table S2).
MtDNA, or its associated nucleoid proteins, appears in dis-
crete foci in the mitochondrial reticulum (most recently investi-
gated by super resolution light microscopy [Brown et al., 2011;
Kukat et al., 2011]) in a punctate pattern that resembles that of
the pattern of GRSF1 immunofluorescence (Figure 1A, insert).
Mass spectrometry analyses of nucleoid proteins have not, how-
ever, identified GRSF1 as a protein component of the mitochon-
drial nucleoid (Bogenhagen et al., 2008; He et al., 2012), and we
confirmed that the GRSF1-positive foci are different from those
containing mtDNA (Figure 4C). In fact, nearly all GRSF1 foci
were juxtaposed to mitochondrial nucleoids, the latter detected
with an anti-DNA antibody (Figure 4C, line graph). GRSF1 foci
were lost upon treatment of cells with mitochondrial replication
and transcription inhibitors (ethidium bromide or actinomycin
D; Figure 4G) but were not affected by inhibition of RNA poly-
merase II (a-amanitin), by inhibition of mitochondrial translation
(chloramphenicol), or by inhibition of the activity of complexes
I, III, or V of the OXPHOS system (by rotenone, antimycin B,
and oligomycin, respectively; data not shown). In rho0 cells,
which are devoid of mitochondrial DNA, and therefore do not
contain any mitochondrial transcripts, GRSF1 protein levels
were decreased and GRSF1 was uniformly distributed in the
mitochondrial network (Figure 4H). Taken together, these data
suggest that GRSF1 forms RNA granules that contain RNA tran-
scribed from the mitochondrial genome.
To test directly whether the GRSF1 foci contained RNA, we
labeled 143Bcellswith the nucleoside analog bromouridine (BrU)
and visualized the BrU-labeled RNA by immunofluorescence98, March 5, 2013 ª2013 Elsevier Inc. 389
Figure 3. Variation in Mitochondrial rRNA and mRNA Levels in Cells Lacking GRSF1
RNA analysis of fibroblasts treated with GRSF1 siRNAs (siRNA1–3), of control siRNA, and of control fibroblasts (control 1 and control 2).
(A) Northern blot analysis and hybridization were performed with probes specific for the mitochondrial mRNAs, rRNAs, and, as a loading control, with a probe for
cytosolic 18S rRNA.
(B) Detection of the ND6 transcript. Northern blot analysis and hybridization with ND6 dsDNA probe (left panel) and ‘‘primer’’ probe (right panel). Schematic
representation of transcripts identified with the ND6 probes (ND5 mRNA and lncND6 RNA are the heavy-strand transcripts; lncND5 RNA/ND6 mRNA and ND6
mRNA are the light-strand transcripts).
(C) Detection of individual mitochondrial tRNAs separated on a urea-polyacrylamide gel by hybridization with oligonucleotide probes complementary to the
mitochondrial tRNAs for Val, Glu, Met, Trp, Lys, and Gln and, as a loading control, the cytosolic tRNA for Glu (cyt Glu).
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discrete foci of newly synthesized RNA, most of which colocal-
ized with the GRSF1-positive foci (Figure 4D, line graph), thus
confirming that the foci contain newly synthesized mitochondrial
transcripts. A small proportion of BrU-labeled RNA colocalized
with mitochondrial DNA (Figure S2), perhaps indicating actively390 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.transcribing nucleoids. Some BrU-positive foci were still visible
in GRSF1 knockdown cells (data not shown), indicating that
formation of the granules is not absolutely dependent on GRSF1.
We next used immunofluorescence/in situ hybridization ex-
periments to demonstrate directly that GRSF1-RNA foci con-
tained mitochondrial mRNA. A fluorescently labeled ND6 probe
Cell Metabolism
GRSF1 Is a Mitochondrial RNA-Binding Proteinproduced a punctate pattern, which colocalized with the GRSF1
foci (Figure 4E), while a fluorescently labeled 12S rRNA probe
stained the mitochondrial network more uniformly (Figure 4F,
middle panel). We conclude that GRSF1 forms RNA granules,
juxtaposed to mitochondrial nucleoids, that are selectively en-
riched in at least one mitochondrial mRNA and two lncRNAs.
GRSF1 Is Required for Assembly of the Mitochondrial
Ribosome and for Recruitment of mRNA and lncRNA
Immunoblot analysis of GRSF1 knockdown cells showed
marked decreases in the steady-state levels of several mito-
chondrial ribosomal proteins (Figures 5A and 5B), especially
those of the large ribosomal subunit (mt-LSU), but no changes
in the steady-state levels of two other mitochondrial RBPs
(LRPPRC, SLIRP), mitochondrial transcription factors (TFAM,
TFB1M, TFB2M, MTERFD3), or the mitochondrial translation
elongation factors EFTu or EFTs. There was, however, a clear
increase in the expression of the translation elongation factor
EFG1 (Figure 5B), perhaps in response to the translation defect.
These results suggested that GRSF1 is also required for ribo-
some assembly or stability. To test this hypothesis, we per-
formed sucrose gradient centrifugation of mitochondria from
control (Figure 6A) and siRNA1-treated cells (Figure 6B). As pre-
dicted by the decreased steady-state levels of the mt-LSU
proteins and the 16S rRNA, the amount of the fully assembled
mt-LSU was substantially decreased. In addition, the pattern of
sedimentation of the small ribosomal subunit (mt-SSU)
appeared different on the sucrose gradient in GRSF1 knock-
down cells (peak in fraction 5 versus fraction 6 in controls), sug-
gesting that it fails to assemble normally in the absence of
GRSF1. The calculated sedimentation coefficient of this com-
plex was 22S, while the fully assembled mt-SSU sediments
as a 28S complex. The combination of abnormal assembly of
the mt-SSU, and the decreased amount of the mt-LSU, re-
sulted in a reduction in monosome formation. To determine if
any proteins were missing in the 22S complex, fraction 5
from the GRSF1 knockdown sucrose gradient and fraction 6
from the control sucrose gradient were TCA precipitated and
analyzed by mass spectrometry. The same set of mt-SSU
proteins was detected in GRSF1 knockdown cells as in control
cells (Table S3). Three known mt-SSU assembly factors,
ERAL1, a homolog of the bacterial Era protein; NOA1 (nitric
oxide-associated 1); and PTCD3 were also present in both
the 22S and 28S mt-SSU by either mass spectrometry or
immunoblot analysis.
To determine if the difference in the size of the small ribosomal
subunit in GRSF1 knockdown cells was caused by a reduction in
the amount of 12S rRNA, we isolated RNA from the sucrose
gradient fractions and determined the distribution of 12S and
16S rRNA across the gradient (Figure 6). The distribution of
12S rRNA in the sucrose gradient of siRNA1-treated cells was
qualitatively different from the control cells. The 12S rRNA was
present in the 22S small ribosomal complex but also peaked in
a fraction of about 33S (Figure 6B), where 25% of total 12S
rRNA was present. The distribution of 16S rRNA was similar in
both the control and siRNA1 cells; however, the total amount
of 16S rRNA in siRNA1-sucrose gradient fractions was about
50% of control, consistent with the reduced steady-state level
seen by northern blot analysis (Figure 3A).CeWe next examined the distribution of mRNAs and the three
lncRNAs in the sucrose gradients. In control cells, the mRNAs
and the lncRNAs sedimented essentially in two pools, one at
the top of the gradient (not associated with ribosomes) and
another that cosedimented with monosomes. There were, how-
ever, several marked differences in the distribution of mRNAs
and lncRNAs in GRSF1 knockdown cells (Figure 6B). First,
the pool of mRNAs and lncRNAs at the top of the gradient
almost disappeared. Second, themRNA for cytbwas distributed
roughly equally between the 22S mt-SSU and the monosome,
while that for ND6 was distributed between the mt-LSU and
the monosome. Strikingly, these mRNAs code for the polypep-
tides whose synthesis is most decreased in GRSF1 knockdown
cells. Lastly, the lncRNA for cytb sedimented almost entirely with
the mt-LSU. Thus, although GRSF1 does not comigrate with the
ribosomal subunits on a sucrose gradient (Figure 6A), it is clearly
essential for the correct loading of both mRNAs and lncRNAs
and ribosomal biogenesis.
DISCUSSION
This study demonstrates that GRSF1, an RBP first reported to
specifically interact with the 50UTRs of viral cytosolic mRNAs,
is predominantly targeted to mitochondria, where it localizes to
RNA granules that lie in close proximity to mitochondrial nucle-
oids. GRSF1 preferentially binds to specific RNAs, including
one mRNA and two lncRNAs, transcribed from the mtDNA
light-strand promoter, all of which contain multiple copies of
the reported consensus binding sequence AGGGD. Loss of
GRSF1 leads to destabilization of several mRNAs and rRNAs,
misloading of RNAs on the ribosome, abnormal ribosome bio-
genesis, and dysregulation of mitochondrial protein synthesis.
GRSF1 thus appears to be necessary for the coordination of
several aspects of posttranscriptional storage, handling, and
translation of mitochondrial RNAs.
Different types of RNA granules (stress granules, processing
bodies, germinal granules, and neuronal transport granules)
have been described in the cytoplasm of somatic and germ cells
(Anderson and Kedersha, 2009; Buchan and Parker, 2009; Liu-
Yesucevitz et al., 2011). Stress granules accumulate in response
to cellular stresses such as nutrient deprivation or viral infection
and serve to halt cytoplasmic translation, promoting cell survival.
Processing bodies regulate mRNA decay, while germinal gran-
ules are responsible formaintaining a pool ofmaternally inherited
mRNAs. Neuronal transport granules can be moved to different
locations in neurons such as the dendrite or synapse to support
local requirements for translation of specific proteins. A general
principle of all cytoplasmic RNA granules is that they contain
translationally silent mRNAs, which may be in dynamic equilib-
riumwithmRNAs associated with actively translating ribosomes.
Previous, quantitative analysis of BrU labeling in mitochondria
identified BrU-positive foci within 200 nm of mitochondrial
nucleoids after short pulse-labeling experiments (Iborra et al.,
2004), consistent with our results, but no protein components
were identified in the BrU-positive foci. A very recent study has
reported so-called D foci, which have been proposed to be the
mitochondrial degradosome (Borowski et al., 2012). These foci
contain a PNPase-hSuv3 protein complex, and a small propor-
tion of them colocalize with newly synthesized RNA.ll Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc. 391
Figure 4. Foci of GRSF1 and RNA
(A) GRSF1 binds light-strand transcripts. RNA was isolated from unbound and elution fractions of GRSF1 and control immunoprecipitation experiments.
Individual transcripts were detected by qRT-PCR or strand-specific qRT-PCR (ND5, ND6, cyt b, lncND5, lncND6, lnc-cyt b). The relative abundance of coim-
munoprecipitated RNA is expressed as a ratio of the levels in the elution over unbound fractions. The purple line represents the relative ratio between GRSF1- and
control-bound RNA. The bars represent the mean of two independent experiments.
(B) Schematic positioning of predicted canonical GRSF1 binding sites (yellow lines) on the heavy-strand transcripts (blue ribbon) and light-strand transcripts (red
ribbon).
(C–H) Localization of GRSF1 by immunofluorescence. (C) GRSF1 foci are in close proximity to mitochondrial DNA, as shown in 143B cells. (D) GRSF1 colocalizes
with mitochondrial RNA. Newly synthesized mitochondrial RNA was visualized by anti-BrdU antibody in 143B cells labeled by BrU. (C and D) The graphs
(legend continued on next page)
Cell Metabolism
GRSF1 Is a Mitochondrial RNA-Binding Protein
392 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.
Figure 5. Lack of GRSF1 Causes Decreased Levels of Mitochondrial
Ribosomal Proteins
(A and B) SDS analysis of steady-state protein levels in fibroblasts treated with
GRSF1 siRNAs (siRNA1–3) and with control siRNA. Indicated proteins were
detected by antibodies in whole-cell extracts (A) or mitochondrial extracts (B).
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GRSF1 Is a Mitochondrial RNA-Binding ProteinThe GRSF1-positive RNA granules accumulate newly synthe-
sized mRNAs and therefore may represent a pool for storing,
sorting, or regulating the translation of mitochondrial mRNAs.
The fact that we saw little evidence for accumulation of unpro-
cessed RNA intermediates by northern blot, or by qRT-PCR
analysis of polycistronic precursors, in GRSF1 knockdown cells
suggests that if processing of polycistronic transcripts does
occur in the RNA granules, which seems likely, it is not GRSF1
dependent. Although EYFP-tagged constructs of several mito-
chondrial RNA-processing enzymes (ELAC2, MRPP1, MRPP3,
PTCD1) have not been reported to accumulate in mitochondrial
foci (Sanchez et al., 2011), their presence in discrete foci may
have been obscured by overexpression of the fluorochrome-
tagged proteins. We identified GRSF1 as a protein that coimmu-
noprecipated with C12orf65, and it is possible that the latter also
colocalizes to RNA granules, but we do not have an antibody to
test this hypothesis. The C12orf65 immunoprecipitate also con-
tained MRPP1 and C1QBP (p32), a protein that localizes to the
mitochondrial matrix (Jiang et al., 1999), but which has also
been implicated in RNA processing in the cytoplasm, lendingrepresent relative intensity of the fluorescence signal along the line in the magnifie
marker) and in situ RNA hybridization with ND6 (E) and 12S rRNA (F) probes in 1
rescence with either ND6 or 12S rRNA. (G) Transcriptional inhibition results in th
nomycin Dwere stainedwith anti-GRSF1 antibody. (H) Lower levels and uniform d
cells colocalizes with the mitochondrial marker MRPL12. The levels of GRSF1 a
extracts from 143B and rho0 cells.
Cesupport to the notion that the RNA granules are involved in
RNA processing. A recent study also suggested that p32 binds
all mitochondrial mRNAs (Yagi et al., 2012), and while it is not
required for their stability, a p32 knockout leads to a severe
defect in mitochondrial translation. Cytoplasmic RNA granules
usually contain many different mRNA species in addition to
a number of RBPs, and a variety of enzymes involved in
translation initiation and RNA processing. While our analyses
suggest that GRSF1 is largely monomeric, a fraction of the
pool does run at higher molecular weights on a gel filtration
column, and it is likely that the GRSF1-positive granules contain
other proteins with which GRSF1 could interact, but these await
identification.
We and others have recently characterized two other mRNA-
binding proteins in mitochondria: LRPPRC and SLIRP (Chujo
et al., 2012; Ruzzenente et al., 2012; Sasarman et al., 2010),
which form an RNP complex stabilizing mRNAs and their poly(A)
tails. The levels of both of these proteins were completely unaf-
fected in GRSF1-knockdown cells, and we found no evidence
that either of them interacted with GRSF1 in immunopre-
cipitation and mass spectrometry experiments. There is some
evidence that the LRPPRC/SLIRP complex binds cotranscrip-
tionally to RNA precursors before they are processed to mature
RNAs (Chujo et al., 2012), so it is possible that the interaction
with LRPPRC/SLIRP occurs upstream, or parallel, to GRSF1-
RNA transactions. Further, as LRPPRC appears to be necessary
to maintain mRNA poly(A) tails by either promoting polyadenyla-
tion or preventing deadenylation (Chujo et al., 2012; Ruzzenente
et al., 2012), it is possible that themature polyadenylatedmRNAs
produced by the LRPPRC/SLIRP complex are subsequently
stored in GRSF1-positive granules.
There does, however, appear to be a rather clear division
of labor between the two posttranscriptional pathways with
respect to specific RNAs. A heart-specific knockout of LRPPRC
had no effect on the stability of the ND6 mRNA (Ruzzenente
et al., 2012), the only mRNA that was highly enriched in GRSF1
immunoprecipitates. ND6 is the only protein-coding gene on
the light strand of mtDNA, and it is the only mitochondrial
mRNA that is not polyadenylated. The ND6 transcript is excep-
tionally G rich (35%) in comparison to all other protein-coding
genes in mtDNA, and it contains four GRSF1 consensus-binding
motifs, so it is perhaps not too surprising to find that GRSF1 pref-
erentially associates with ND6 mRNA. However, this does not
appear to be the whole story, as other transcripts, such as that
for COX I, have three potential GRSF1 binding motifs but are
not enriched in GRSF1 immunoprecipitates. RNAseq experi-
ments have identified three specific, abundant lncRNAs tran-
scribed from the ND5, ND6, and cyt b genes (Rackham et al.,
2011), and strand-specific qRT-PCR revealed that those for cyt
b and ND5, both of which contain multiple AGGGD consensus
binding sequences (10 and 21, respectively), are highly enriched
in GRSF1 immunoprecipitates. The RNAs that bind GRSF1 ared panel. (E and F) Immunofluorescence of GRSF1 and MRPL12 (mitochondrial
43B cells. The last panel in (E) and (F) shows a merge of GRSF1 immunofluo-
e loss of GRSF1 foci. Fibroblasts treated with ethidium bromide (EtBr) or acti-
istribution of GRSF1 protein in rho0 cells. Diffuse GRSF1 immunostaining in rho0
nd controls (SDHA, TFAM) were determined by SDS-PAGE of mitochondrial
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Figure 6. Lack of GRSF1 Leads to Misloading of RNAs and Impaired Assembly of the Mitochondrial Ribosome
(A and B) Identification of mitochondrial RNA and mitochondrial ribosomal proteins by sucrose gradient centrifugation in control siRNA-treated cells (A) and
GRSF1 siRNA1-treated cells (B). Individual transcripts (rRNA, mRNA, and lncRNA) were detected by qRT-PCR or strand-specific qRT-PCR, and the abundance
of each transcript is shown as percentage of the sum of the abundance in all fractions. Themigration of the small (28S) and the large (39S) ribosomal subunits and
themonosome (55S) are indicated for reference. Themigration of the small ribosomal subunit (22S) in GRSF1 siRNA1-treated cells and the 33S peak of 12S rRNA
are also indicated.
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form consensus binding sequences for other RNA-binding pro-
teins such as FMRP, which is associated with fragile X syndrome
(Darnell et al., 2001), and which is implicated in the regulation of
cytosolic mRNA translation at synapses (Bugaut and Balasubra-394 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.manian, 2012). The QGRS-H Predictor algorithm (Menendez
et al., 2012) predicts 65 possible G quadruplex structures in
lnccytb, four inND6, and ten in lncND5. None of the heavy-stand
transcripts are predicted to form G quadruplex structures, and
none were significantly enriched in GRSF1 immunoprecipitates,
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represent bona fide GRSF1 binding motifs. Interestingly, all
sequenced vertebrate mitochondrial genomes have a robust
strand-specific G-C skew, and GRSF1 does not appear to
have evolutionarily conserved homologs beyond the teleosts.
A somewhat unexpected result of the knockdown of GRSF1
was the effect on mitochondrial ribosomal biogenesis, as
GRSF1 does not cosediment with mitochondrial ribosomes on
sucrose gradients. In all organisms studied so far, ribosomal
biogenesis is a complex multistep pathway, in which rRNA plays
a crucial role. The process is thought to involve progressive
stabilization of rRNA structures based on the successive binding
of the structural protein subunits (Shajani et al., 2011). Although
very little is known about the biogenesis of mammalian mito-
chondrial ribosomes, based on their evolutionary relationship
with eubacterial ribosomes, one might expect some conserved
elements in the pathway. The bacterial 70S ribosome is com-
posed of a small subunit (30S), which contains 21 proteins and
16S rRNA, and a large subunit (50S), which contains 33 proteins
and two rRNAs (23S and 5S). Bacterial ribosome assemblymaps
have been proposed based on both in vitro and in vivo studies
(Shajani et al., 2011). Human mitochondrial ribosomes differ
substantially in both the composition and physical properties
from the bacterial ribosome, as they contain about half the
RNA and nearly twice as many proteins (O’Brien, 2002). Homo-
logs of all but 12 bacterial ribosomal proteins exist in mitochon-
dria together with 37 additional proteins. Interestingly, several of
the bacterial small ribosomal proteins that do not have human
homologs (S3, S4, S19, S20) are essential in the first steps
of the ribosome assembly (Held et al., 1974; Talkington et al.,
2005), suggesting that the assembly pathway has also evolved
significantly in concert with the physical composition of the
ribosome.
Knockdown ofGRSF1 leads to the formation of a subassembly
of the mt-SSU that sediments as a 22S particle. To our knowl-
edge, a subassembly of the mt-SSU has never been reported.
The size of this subassembly is similar to the bacterial ribosomal
assembly intermediate RI30, which is formed at low tempera-
tures, and which contains 16S rRNA and 15 ribosomal proteins
(Shajani et al., 2011). In contrast, the 22S mt-SSU of GRSF1
knockdown cells contained both the 12S rRNA and all the
small ribosomal proteins, which were also present in the 28S
mt-SSU. The lack of GRSF1 protein also resulted in decreased
steady-state levels of several mt-LSU proteins, and of the fully
assembled 39S mt-LSU on sucrose gradients; however, the
sedimentation of themt-LSUwas identical in GRSF1 knockdown
cells and controls.
The effects of GRSF1 knockdown on ribosome assembly
could be an indirect result of the decreased abundance of the
rRNAs (especially the 16S RNA) and misloading of mRNA and
lncRNA onto ribosomal subunits. lncRNAs have been implicated
in a wide variety of processes regulating gene expression (Wang
and Chang, 2011), so it is difficult to predict the function of the
mitochondrial lncRNAs. It is clear from our experiments that
they normally associate with monosomes, suggesting that they
play some role in the regulation of mitochondrial translation,
perhaps in ribosome assembly, or as scaffolds or guides. They
are also destabilized, and one of them is misloaded onto ribo-
somes, in the absence of GRSF1. Although the mitochondrialCelncRNAs were suggested to form intermolecular duplex struc-
tures, based on RNase sensitivity experiments (Rackham et al.,
2011), it is possible that the resistance to RNase digestion is
attributable either to GRSF1 or their association with ribosomal
proteins. Although we did not investigate the pattern of cosedi-
mentation of all of the mRNAs on sucrose gradients, the fact
that the two polypeptides (cytb and ND6) whose synthesis is
most reduced in GRSF1 knockdown cells, are misloaded on in-
dividuual ribosome subunits is consistent with the idea that
GRSF1 plays some role in the recruitment of ribosome subunits
in translation initiation and formation of the monosome.
In summary, this study provides strong evidence for the role of
the RBP GRSF1 in the formation of mitochondrial RNA granules,
which appear to be crucial for the posttranscriptional storage,
handling, and translation of mitochondrial RNAs; in addition,
this study implicates lncRNAs in the regulation of mitochondrial
translation. The composition of the RNA granules and themolec-
ular mechanisms by which GRSF1 regulates RNA loading onto
ribosomes will require further detailed investigation.
EXPERIMENTAL PROCEDURES
Cell Lines
Primary control fibroblast cell lines were immortalized by transduction with
a retroviral vector expressing the HPV-16 E7 gene and a retroviral vector
expressing the catalytic component of human telomerase (htert) (Yao and
Shoubridge, 1999). The fibroblasts, HEK293, 143B, and 143B rho0 cell lines
were grown in high-glucose Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum, at 37C in an atmosphere of 5% CO2.
The medium for the 143B rho0 cell line was supplemented with 50 mg/ml
of uridine.
siRNA Transfection
RNA interference was used for transient knockdown of GRSF1 in control
fibroblasts. Three Stealth RNA interference duplex constructs against
human GRSF1 (Invitrogen), designed using Block-iT RNAi Express
(http://rnaidesigner.invitrogen.com/rnaiexpress), were used (HSS104516,
HSS104517, HSS179021). The three stealth siRNAs and the fluorescent oligo
control Block-iT Alexa FluorRed (control siRNA, Invitrogen) were transiently
transfected into control fibroblasts at a final concentration of 12 nM using
Lipofectamine RNAiMAX (Invitrogen), according to the manufacturer’s speci-
fications. The transfection was repeated on day 3, and the cells were
harvested on day 6 for analysis.
Mitochondrial Isolation and Localization Experiments
HEK293, 143B, and 143B rho0 cells and fibroblasts were resuspended in ice-
cold 250 mM sucrose/10 mM Tris-HCl/1 mM EDTA (pH 7.4) and homogenized
with seven passes in a prechilled, zero clearance homogenizer (Kimble/
Kontes, Vineland, NJ). EDTA was omitted from the buffer in the mitochondrial
preparation for sucrose gradient fractionation. A postnuclear supernatant was
obtained by centrifugation of the samples twice for 10 min at 600 g. Mitochon-
dria were pelleted by centrifugation for 10 min at 10,000 g and washed once in
the same buffer. Subcellular fractionation of HEK293 mitochondria was per-
formed as described (Wieckowski et al., 2009). For submitochondrial localiza-
tion experiments, mitochondria from HEK293 were further extracted with
100mM alkaline carbonate at a pH of 11.5 as previously described (Weraarpa-
chai et al., 2009), and the relevant fractions were analyzed by SDS-PAGE. Size
exclusion chromatography was performed as described previously (Kaufman
et al., 2007).
Enzyme Assay and Protein Concentration Measurements
A spectrophotometric assay of whole-cell extracts from control and siRNA-
treated cells was used to measure the enzymatic activity of COX as described
previously (Antonicka et al., 2003a). Protein concentration was determined by
Bradford assay.ll Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc. 395
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Blue native PAGE (BN-PAGE) was used to separate individual OXPHOS
complexes. Mitoplasts, prepared from fibroblasts by treatment with 0.8 mg
of digitonin per milligram of protein, or isolated mitochondria were solubilized
with 1% lauryl maltoside. Solubilized samples (10–20 mg) were run in the first
dimension on 6%–15% polyacrylamide gradient gels as described in detail
elsewhere (Leary and Sasarman, 2009). For the second-dimension analysis,
BN-PAGE/SDS-PAGE was carried out as detailed previously (Antonicka
et al., 2003b).
SDS-PAGE was used to separate denatured whole-cell extracts, isolated
mitochondrial extracts and fractions from either alkaline carbonate extraction,
size exclusion experiment, or sucrose gradient sedimentation. In general,
whole cells were extracted with 1.5% lauryl maltoside/PBS, after which
20 mg of protein was run on either 10%, 12%, or 15% polyacrylamide gels.
Separated proteins were transferred to a nitrocellulose membrane, and immu-
noblot analysis was performed with the indicated antibodies.
Antibodies
The following antibodies were used in this study: anti-GRSF1(Sigma-Aldrich),
anti-SDHA (Abcam), anti-Porin (EMD Calbiochem), anti-Prohibitin (Abcam),
anti-a-Tubulin (Santa Cruz Biotechnology), anti-COX I (Abcam), anti-COX II
(Abcam), anti-COX IV (Abcam), anti-a ATPase (Abcam), anti-CORE1 (Abcam),
anti-ND1 (a kind gift of Anne Lombes), anti-DNA (PROGEN Biotechnik
GmbH), anti-BrdU (Sigma-Aldrich, Abcam), anti-LRPPRC (in house), anti-
EFG1 (in house), anti-EFTu/Ts (a kind gift from Linda Spremulli), anti-Slirp
(Abcam), anti-MRPL11 (Sigma-Aldrich), anti-MRPL12 (Novus Biologicals),
anti-MRPL14 (Sigma-Aldrich), anti-MRPL32 (a kind gift from Thomas Langer),
anti-MRPL44 (Proteintech Group), anti-MRPS18B (Proteintech Group),
anti-MRPS27 (Proteintech Group), anti-MRPS22 (Proteintech Group), anti-
MRPS35 (Sigma-Aldrich), anti-cytochrome c (Santa Cruz Biotechnology),
anti-AIF (Santa Cruz Biotechnology), anti-TFAM (a kind gift of Alexandra Trifu-
novic), anti-TFB1M (Sigma-Aldrich), anti-TFB2M (Abgent), and anti-MTERFD3
(Sigma-Aldrich).
Radiotracer Labeling of Mitochondrial Translation Products
Pulse labeling of mitochondrial translation products in control and siRNA-
treated fibroblasts was performed with 200 mCi/ml of a [35S]-methionine/
cysteine mix (Perkin Elmer) in DMEM lacking methionine and cysteine and
containing 100 mg/ml of a cytoplasmic translation inhibitor emetine for
60 min as described in detail elsewhere (Sasarman and Shoubridge, 2012).
Northern Blotting and Northern-PAGE Analysis
Northern blotting was carried out essentially as described previously (Weraar-
pachai et al., 2009). For detection of the ND6 transcript, a ‘‘primer’’ probe was
32P labeled by the end-labeling technique. The ‘‘primer’’ probe was a mix of
three sequence-specific oligonucleotides complimentary to the ND6 tran-
script: 50-GCTGTAGTATATCCAAAGACAACCATCATT-30, 50-AACCAGTAAC
TACTACTAATCAACGCCCAT-30, and 50-ACCAATCCTACCTCCATCGCTAA
CCCCACT-30. For northern-PAGE analysis of mitochondrial tRNAs, 5 mg total
RNA from control and siRNA-treated fibroblasts was run on a 10% polyacryl-
amide gel containing 7M urea, followed by transfer to Hybond N+ membrane
(GE Healthcare). Prehybridization and hybridization were carried out in
EXPRESSHyb solution (Clontech) according to the manufacturer’s instruc-
tions. The oligonucleotides used for the generation of the 32P-labeled probes
by the end-labeling technique had the following sequences: 50-TGGTATT
CTCGCACGGACTACAAC-30 for mt tRNAGlu, 50-TGGTAGTACGGCAAGGG
TATAACC-30 for mt tRNAMet, 50-TGGCTAGGACTATGAGAATCGAAC-30 for
tRNAGln, 50-TGGTCACTGTAAAGAGGTGTTGGT-30 for mt tRNALys, 50-TGGC
AGAAATTAAGTATTGCAACT-30 for mt tRNATrp, 50-TGGTCAGAGCGGTCA
AGTTAAGTT-30 for mt tRNAVal, and 50-TGGTGGTTCCCTGACCGGGAATCG-
30 for cytoplasmic tRNAcyt Glu.
qRT-PCR
Total RNA isolated from control and siRNA-treated cells, RNA isolated from
unbound and elution fractions from the immunoprecipitation experiment,
and RNA isolated from sucrose gradient fractions were DNase I treated exten-
sively to remove mtDNA. The absence of mtDNA was verified by PCR. qRT-
PCR analysis for all mitochondrial transcripts was performed at the Institute396 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.for Research in Immunology and Cancer (IRIC) using either Taqman probes
(Applied Biosystems) or Universal Probe Library (Roche) with appropriate
primer pairs (available on request). Strand-specific qRT-PCR was essentially
carried out as described previously (Rackham et al., 2011), with the exception
that Taqman-specific probes were used to detect noncoding cyt b, noncoding
ND5, and coding and noncoding ND6 transcripts. The levels of preprocessed
transcript junctions were measured as previously described (Sanchez et al.,
2011).
Immunocytochemistry
Control fibroblast cells, 143B and 143B rho0 cells grown on coverslips,
were fixed with 4% formaldehyde solution, solubilized by Triton X-100,
and incubated with the indicated antibodies. For treatment with indicated
inhibitors, actinomycin D (40 mg/ml) or EtBr (50 ng/ml) was added to the
media 12 hr prior to formaldehyde fixation. For BrU labeling, cells grown
on coverslips were incubated with 2.5 mM BrU for 30 min prior to fixation.
Anti-BrdU antibody was used to detect BrU-labeled RNA. The appro-
priate anti-species secondary antibodies coupled with Alexa fluorochromes
(Invitrogen) were subsequently used at a dilution of 1:2,000. Cells were
imaged with either Zeiss Axio Imager A1 or Olympus FV1000 confocal scan-
ning microscope.
Combination of Immunofluorescence and RNA FISH
Combination of immunofluorescence and RNA FISH was performed essen-
tially as described previously (Chaumeil et al., 2008) with minor modifications.
50Cy3-labeled oligonucleotide probes (1 mg) were used: 50Cy3- CCATGCCT
CAGGATACTCCTCAATAGCCATCGCTGTAGTATATCCAAAGA-30 for ND6,
and 50Cy3- TGGCTGGCACGAAATTGACCAACCCTGGGGTTAGTATAGCTTA
GTTAAAC-30 for 12S. Probes were resuspended in 5 ml of formamide and
denatured at 75C for 7 min, and 35 ml of EXPRESSHyb solution (Clontech)
was added. Hybridization was performed at 37C for 1.5 hr.
Sucrose Gradient Sedimentation
Mitochondria from control siRNA and siRNA1-treated cells (400 mg) were
lysed in lysis buffer (260 mM sucrose, 100 mM KCl, 20 mM MgCl2, 10 mM
Tris-Cl [pH 7.5], 1% Triton X-100, 5 mM b-mercaptoethanol, protease inhibitor
cocktail without EDTA [Roche]) on ice for 20 min. Lysates were cleared prior to
loading onto the sucrose density gradient by centrifugation at 9,400 g for
45 min at 4C. Lysates were loaded on a 1 ml 10%–30% discontinuous
sucrose gradient (50 mM Tris-Cl, 100 mM KCl, 10 mMMgCl2) and centrifuged
at 32,000 rpm for 130 min in a Beckman SW60-Ti rotor. After centrifugation,
14 fractions were collected from the top and used for further analysis
(immunoblotting and qRT-PCR). For mass spectrometry analysis, one-half
of fractions 5 and 6 were TCA precipitated and analyzed on an Orbitrap
(Thermo Scientific, Watlham, MA) at the Institute de Recherches Cliniques
de Montreal.
RNA Immunoprecipitation
Mitochondria from HEK293 cells (400 mg) were extracted in 100 ml extraction
buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mMMgCl2, 100 U/ml RNase
inhibitor, 3 mM vanadylate ribonuclease complex, 1% NP-40, and complete
protease inhibitors without EDTA [Roche]) on ice for 40 min, with occasional
vortexing. The extract was centrifuged at 25,000 g at 4C for 40 min, and
the supernatant was precleared overnight with noncoated Dynabeads Protein
A (Invitrogen) to reduce nonspecific RNA binding to the beads. Binding of anti-
GRSF1 antibody to Dynabeads Protein A (Invitrogen) was performed accord-
ing to themanufacturer’s instructions (version number 004), with the exception
of the durations of the incubation of the antibody with the beads, which was
carried out overnight. The precleared extract was then used in the immunopre-
cipitation experiment with GRSF1-antibody crosslinked beads (GRSF1-IP)
and noncoated beads (control-IP). The immunoprecipitation reaction was per-
formed at room temperature for 2 hr.
To isolate RNA following the immunoprecipitation reaction, the beads were
washed five times with extraction buffer, then incubated for 30 min at 37C
with DNase I, followed by a 30 min incubation at 55C with Proteinase K in
the presence of 0.1% SDS. Samples were then supplemented with EDTA
(5 mM) and 1 mg of yeast tRNA. The magnetic beads were then discarded,
and phenol-chloroform extraction of RNA was subsequently performed.
Cell Metabolism
GRSF1 Is a Mitochondrial RNA-Binding ProteinSUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and three tables and can be
found with this article at http://dx.doi.org/10.1016/j.cmet.2013.02.006.
ACKNOWLEDGMENTS
This research was supported by a grant from the CIHR (FRN15460 to E.A.S.).
V.P. is supported by a postdoctoral fellowship from the FRSQ. We thank Tim
Johns for technical assistance.
Received: July 24, 2012
Revised: December 18, 2012
Accepted: February 6, 2013
Published: March 5, 2013
REFERENCES
Anderson, P., and Kedersha, N. (2009). RNA granules: post-transcriptional and
epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 10,
430–436.
Antonicka, H., Mattman, A., Carlson, C.G., Glerum, D.M., Hoffbuhr, K.C.,
Leary, S.C., Kennaway, N.G., and Shoubridge, E.A. (2003a). Mutations in
COX15 produce a defect in the mitochondrial heme biosynthetic pathway,
causing early-onset fatal hypertrophic cardiomyopathy. Am. J. Hum. Genet.
72, 101–114.
Antonicka, H., Ogilvie, I., Taivassalo, T., Anitori, R.P., Haller, R.G., Vissing, J.,
Kennaway, N.G., and Shoubridge, E.A. (2003b). Identification and character-
ization of a common set of complex I assembly intermediates in mitochondria
from patients with complex I deficiency. J. Biol. Chem. 278, 43081–43088.
Antonicka, H., Sasarman, F., Kennaway, N.G., and Shoubridge, E.A. (2006).
Themolecular basis for tissue specificity of the oxidative phosphorylation defi-
ciencies in patients with mutations in the mitochondrial translation factor
EFG1. Hum. Mol. Genet. 15, 1835–1846.
Antonicka, H., Ostergaard, E., Sasarman, F., Weraarpachai, W., Wibrand, F.,
Pedersen, A.M., Rodenburg, R.J., van der Knaap, M.S., Smeitink, J.A.,
Chrzanowska-Lightowlers, Z.M., and Shoubridge, E.A. (2010). Mutations in
C12orf65 in patients with encephalomyopathy and a mitochondrial translation
defect. Am. J. Hum. Genet. 87, 115–122.
Baughman, J.M., Nilsson, R., Gohil, V.M., Arlow, D.H., Gauhar, Z., and
Mootha, V.K. (2009). A computational screen for regulators of oxidative phos-
phorylation implicates SLIRP in mitochondrial RNA homeostasis. PLoS Genet.
5, e1000590. http://dx.doi.org/10.1371/journal.pgen.1000590.
Bogenhagen, D.F., Rousseau, D., and Burke, S. (2008). The layered structure
of human mitochondrial DNA nucleoids. J. Biol. Chem. 283, 3665–3675.
Borowski, L.S., Dziembowski, A., Hejnowicz, M.S., Stepien, P.P., and
Szczesny, R.J. (2012). Human mitochondrial RNA decay mediated by
PNPase-hSuv3 complex takes place in distinct foci. Nucleic Acids Res. 41,
1223–1240.
Brown, T.A., Tkachuk, A.N., Shtengel, G., Kopek, B.G., Bogenhagen, D.F.,
Hess, H.F., and Clayton, D.A. (2011). Superresolution fluorescence imaging
of mitochondrial nucleoids reveals their spatial range, limits, and membrane
interaction. Mol. Cell. Biol. 31, 4994–5010.
Brzezniak, L.K., Bijata, M., Szczesny, R.J., and Stepien, P.P. (2011).
Involvement of human ELAC2 gene product in 30 end processing of mitochon-
drial tRNAs. RNA Biol. 8, 616–626.
Buchan, J.R., and Parker, R. (2009). Eukaryotic stress granules: the ins and
outs of translation. Mol. Cell 36, 932–941.
Bugaut, A., and Balasubramanian, S. (2012). 50-UTR RNA G-quadruplexes:
translation regulation and targeting. Nucleic Acids Res. 40, 4727–4741.
Chaumeil, J., Augui, S., Chow, J.C., and Heard, E. (2008). Combined immuno-
fluorescence, RNA fluorescent in situ hybridization, and DNA fluorescent
in situ hybridization to study chromatin changes, transcriptional activity,
nuclear organization, and X-chromosome inactivation. Methods Mol. Biol.
463, 297–308.CeChrzanowska-Lightowlers, Z.M., Pajak, A., and Lightowlers, R.N. (2011).
Termination of protein synthesis in mammalian mitochondria. J. Biol. Chem.
286, 34479–34485.
Chujo, T., Ohira, T., Sakaguchi, Y., Goshima, N., Nomura, N., Nagao, A., and
Suzuki, T. (2012). LRPPRC/SLIRP suppresses PNPase-mediated mRNA
decay and promotes polyadenylation in human mitochondria. Nucleic Acids
Res. 40, 8033–8047.
Darnell, J.C., Jensen, K.B., Jin, P., Brown, V., Warren, S.T., and Darnell, R.B.
(2001). Fragile Xmental retardation protein targets G quartet mRNAs important
for neuronal function. Cell 107, 489–499.
Davies, S.M., Rackham, O., Shearwood, A.M., Hamilton, K.L., Narsai, R.,
Whelan, J., and Filipovska, A. (2009). Pentatricopeptide repeat domain protein
3 associates with the mitochondrial small ribosomal subunit and regulates
translation. FEBS Lett. 583, 1853–1858.
Davies, S.M., Lopez Sanchez, M.I., Narsai, R., Shearwood, A.M., Razif, M.F.,
Small, I.D., Whelan, J., Rackham, O., and Filipovska, A. (2012). MRPS27 is
a pentatricopeptide repeat domain protein required for the translation of mito-
chondrially encoded proteins. FEBS Lett. 586, 3555–3561.
Glisovic, T., Bachorik, J.L., Yong, J., and Dreyfuss, G. (2008). RNA-binding
proteins and post-transcriptional gene regulation. FEBS Lett. 582, 1977–1986.
Guan, M.X., Enriquez, J.A., Fischel-Ghodsian, N., Puranam, R.S., Lin, C.P.,
Maw, M.A., and Attardi, G. (1998). The deafness-associated mitochondrial
DNA mutation at position 7445, which affects tRNASer(UCN) precursor pro-
cessing, has long-range effects on NADH dehydrogenase subunit ND6 gene
expression. Mol. Cell. Biol. 18, 5868–5879.
Haque, M.E., Koc, H., Cimen, H., Koc, E.C., and Spremulli, L.L. (2011).
Contacts between mammalian mitochondrial translational initiation factor 3
and ribosomal proteins in the small subunit. Biochim. Biophys. Acta 1814,
1779–1784.
He, J., Cooper, H.M., Reyes, A., Di Re, M., Sembongi, H., Litwin, T.R., Gao, J.,
Neuman, K.C., Fearnley, I.M., Spinazzola, A., et al. (2012). Mitochondrial
nucleoid interacting proteins support mitochondrial protein synthesis.
Nucleic Acids Res. 40, 6109–6121.
Held, W.A., Ballou, B., Mizushima, S., and Nomura, M. (1974). Assembly
mapping of 30 S ribosomal proteins from Escherichia coli. Further studies.
J. Biol. Chem. 249, 3103–3111.
Holzmann, J., Frank, P., Lo¨ffler, E., Bennett, K.L., Gerner, C., and Rossmanith,
W. (2008). RNase P without RNA: identification and functional reconstitution of
the human mitochondrial tRNA processing enzyme. Cell 135, 462–474.
Iborra, F.J., Kimura, H., and Cook, P.R. (2004). The functional organization of
mitochondrial genomes in human cells. BMC Biol. 2, 9. http://dx.doi.org/10.
1186/1741-7007-2-9.
Jablonski, J.A., and Caputi, M. (2009). Role of cellular RNA processing factors
in human immunodeficiency virus type 1 mRNA metabolism, replication, and
infectivity. J. Virol. 83, 981–992.
Jiang, J., Zhang, Y., Krainer, A.R., and Xu, R.M. (1999). Crystal structure of
human p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc.
Natl. Acad. Sci. USA 96, 3572–3577.
Kash, J.C., Cunningham, D.M., Smit, M.W., Park, Y., Fritz, D., Wilusz, J., and
Katze, M.G. (2002). Selective translation of eukaryotic mRNAs: functional
molecular analysis of GRSF-1, a positive regulator of influenza virus protein
synthesis. J. Virol. 76, 10417–10426.
Kaufman, B.A., Durisic, N., Mativetsky, J.M., Costantino, S., Hancock, M.A.,
Grutter, P., and Shoubridge, E.A. (2007). Themitochondrial transcription factor
TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like
structures. Mol. Biol. Cell 18, 3225–3236.
Keene, J.D. (2007). RNA regulons: coordination of post-transcriptional events.
Nat. Rev. Genet. 8, 533–543.
Kukat, C., Wurm, C.A., Spa˚hr, H., Falkenberg, M., Larsson, N.G., and Jakobs,
S. (2011). Super-resolution microscopy reveals that mammalian mitochondrial
nucleoids have a uniform size and frequently contain a single copy of mtDNA.
Proc. Natl. Acad. Sci. USA 108, 13534–13539.
Leary, S.C., and Sasarman, F. (2009). Oxidative phosphorylation: synthesis
of mitochondrially encoded proteins and assembly of individual structuralll Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc. 397
Cell Metabolism
GRSF1 Is a Mitochondrial RNA-Binding Proteinsubunits into functional holoenzyme complexes. Methods Mol. Biol. 554,
143–162.
Lickert, H., Cox, B., Wehrle, C., Taketo, M.M., Kemler, R., and Rossant, J.
(2005). Dissecting Wnt/beta-catenin signaling during gastrulation using RNA
interference in mouse embryos. Development 132, 2599–2609.
Liu-Yesucevitz, L., Bassell, G.J., Gitler, A.D., Hart, A.C., Klann, E., Richter,
J.D., Warren, S.T., and Wolozin, B. (2011). Local RNA translation at the
synapse and in disease. J. Neurosci. 31, 16086–16093.
Lunde, B.M., Moore, C., and Varani, G. (2007). RNA-binding proteins: modular
design for efficient function. Nat. Rev. Mol. Cell Biol. 8, 479–490.
Menendez, C., Frees, S., and Bagga, P.S. (2012). QGRS-H Predictor: a web
server for predicting homologous quadruplex forming G-rich sequence
motifs in nucleotide sequences. Nucleic Acids Res. 40(Web Server issue),
W96–W103.
Mercer, T.R., Neph, S., Dinger, M.E., Crawford, J., Smith, M.A., Shearwood,
A.M., Haugen, E., Bracken, C.P., Rackham, O., Stamatoyannopoulos, J.A.,
et al. (2011). The human mitochondrial transcriptome. Cell 146, 645–658.
Mootha, V.K., Lepage, P., Miller, K., Bunkenborg, J., Reich, M., Hjerrild, M.,
Delmonte, T., Villeneuve, A., Sladek, R., Xu, F., et al. (2003). Identification of
a gene causing human cytochrome c oxidase deficiency by integrative geno-
mics. Proc. Natl. Acad. Sci. USA 100, 605–610.
O’Brien, T.W. (2002). Evolution of a protein-rich mitochondrial ribosome: impli-
cations for human genetic disease. Gene 286, 73–79.
Pagliarini, D.J., Calvo, S.E., Chang, B., Sheth, S.A., Vafai, S.B., Ong, S.E.,
Walford, G.A., Sugiana, C., Boneh, A., Chen, W.K., et al. (2008). A mitochon-
drial protein compendium elucidates complex I disease biology. Cell 134,
112–123.
Park, Y.W., Wilusz, J., and Katze, M.G. (1999). Regulation of eukaryotic protein
synthesis: selective influenza viral mRNA translation is mediated by the cellular
RNA-binding protein GRSF-1. Proc. Natl. Acad. Sci. USA 96, 6694–6699.
Qian, Z., and Wilusz, J. (1994). GRSF-1: a poly(A)+ mRNA binding protein
which interacts with a conserved G-rich element. Nucleic Acids Res. 22,
2334–2343.
Rackham, O., Shearwood, A.M., Mercer, T.R., Davies, S.M., Mattick, J.S., and
Filipovska, A. (2011). Long noncoding RNAs are generated from the mitochon-
drial genome and regulated by nuclear-encoded proteins. RNA 17, 2085–
2093.
Rorbach, J., and Minczuk, M. (2012). The post-transcriptional life of mamma-
lian mitochondrial RNA. Biochem. J. 444, 357–373.
Ruzzenente, B., Metodiev, M.D., Wredenberg, A., Bratic, A., Park, C.B.,
Ca´mara, Y., Milenkovic, D., Zickermann, V., Wibom, R., Hultenby, K., et al.
(2012). LRPPRC is necessary for polyadenylation and coordination of transla-
tion of mitochondrial mRNAs. EMBO J. 31, 443–456.
Sanchez, M.I., Mercer, T.R., Davies, S.M., Shearwood, A.M., Nyga˚rd, K.K.,
Richman, T.R., Mattick, J.S., Rackham, O., and Filipovska, A. (2011). RNA pro-
cessing in human mitochondria. Cell Cycle 10, 2904–2916.
Sasarman, F., and Shoubridge, E.A. (2012). Radioactive labeling of mitochon-
drial translation products in cultured cells. Methods Mol. Biol. 837, 207–217.
Sasarman, F., Brunel-Guitton, C., Antonicka, H.,Wai, T., and Shoubridge, E.A.;
LSFC Consortium. (2010). LRPPRC and SLIRP interact in a ribonucleoprotein398 Cell Metabolism 17, 386–398, March 5, 2013 ª2013 Elsevier Inc.complex that regulates posttranscriptional gene expression in mitochondria.
Mol. Biol. Cell 21, 1315–1323.
Schaub, M.C., Lopez, S.R., and Caputi, M. (2007). Members of the hetero-
geneous nuclear ribonucleoprotein H family activate splicing of an HIV-1
splicing substrate by promoting formation of ATP-dependent spliceosomal
complexes. J. Biol. Chem. 282, 13617–13626.
Schmitz-Linneweber, C., and Small, I. (2008). Pentatricopeptide repeat
proteins: a socket set for organelle gene expression. Trends Plant Sci. 13,
663–670.
Shajani, Z., Sykes, M.T., and Williamson, J.R. (2011). Assembly of bacterial
ribosomes. Annu. Rev. Biochem. 80, 501–526.
Slomovic, S., Laufer, D., Geiger, D., and Schuster, G. (2005). Polyadenylation
and degradation of human mitochondrial RNA: the prokaryotic past leaves its
mark. Mol. Cell. Biol. 25, 6427–6435.
Smeitink, J.A., Elpeleg, O., Antonicka, H., Diepstra, H., Saada, A., Smits, P.,
Sasarman, F., Vriend, G., Jacob-Hirsch, J., Shaag, A., et al. (2006). Distinct
clinical phenotypes associated with a mutation in the mitochondrial translation
elongation factor EFTs. Am. J. Hum. Genet. 79, 869–877.
Talkington, M.W., Siuzdak, G., and Williamson, J.R. (2005). An assembly land-
scape for the 30S ribosomal subunit. Nature 438, 628–632.
Temperley, R.J., Wydro, M., Lightowlers, R.N., and Chrzanowska-Lightowlers,
Z.M. (2010). Human mitochondrial mRNAs—like members of all families,
similar but different. Biochim. Biophys. Acta 1797, 1081–1085.
Ufer, C., Wang, C.C., Fa¨hling, M., Schiebel, H., Thiele, B.J., Billett, E.E., Kuhn,
H., and Borchert, A. (2008). Translational regulation of glutathione peroxidase
4 expression through guanine-rich sequence-binding factor 1 is essential for
embryonic brain development. Genes Dev. 22, 1838–1850.
Wang, K.C., and Chang, H.Y. (2011). Molecular mechanisms of long noncod-
ing RNAs. Mol. Cell 43, 904–914.
Weraarpachai, W., Antonicka, H., Sasarman, F., Seeger, J., Schrank, B.,
Kolesar, J.E., Lochmu¨ller, H., Chevrette, M., Kaufman, B.A., Horvath, R., and
Shoubridge, E.A. (2009). Mutation in TACO1, encoding a translational activator
of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh
syndrome. Nat. Genet. 41, 833–837.
Wieckowski, M.R., Giorgi, C., Lebiedzinska, M., Duszynski, J., and Pinton, P.
(2009). Isolation of mitochondria-associated membranes and mitochondria
from animal tissues and cells. Nat. Protoc. 4, 1582–1590.
Xu, F., Ackerley, C., Maj, M.C., Addis, J.B., Levandovskiy, V., Lee, J., Mackay,
N., Cameron, J.M., and Robinson, B.H. (2008). Disruption of a mitochondrial
RNA-binding protein gene results in decreased cytochrome b expression
and amarked reduction in ubiquinol-cytochrome c reductase activity inmouse
heart mitochondria. Biochem. J. 416, 15–26.
Yagi, M., Uchiumi, T., Takazaki, S., Okuno, B., Nomura, M., Yoshida, S., Kanki,
T., and Kang, D. (2012). p32/gC1qR is indispensable for fetal development and
mitochondrial translation: importance of its RNA-binding ability. Nucleic Acids
Res. 40, 9717–9737.
Yao, J., and Shoubridge, E.A. (1999). Expression and functional analysis of
SURF1 in Leigh syndrome patients with cytochrome c oxidase deficiency.
Hum. Mol. Genet. 8, 2541–2549.
